R. G. Robinson and R. E. Jorge, Post-Stroke Depression: A Review, Am J Psychiatry, vol.173, issue.3, pp.221-252, 2016.

D. A. Levine, A. T. Galecki, and K. M. Langa, Trajectory of Cognitive Decline After Incident Stroke, JAMA, vol.314, issue.1, pp.41-51, 2015.

J. S. Siegel, L. E. Ramsey, and A. Z. Snyder, Disruptions of network connectivity predict impairment in multiple behavioral domains after stroke, Proc Natl Acad Sci, vol.113, issue.30, pp.4367-76, 2016.

J. Zhang, Y. Zhang, S. Xing, Z. Liang, and J. Zeng, Secondary neurodegeneration in remote regions after focal cerebral infarction: a new target for stroke management?, Stroke, vol.43, issue.6, pp.1700-1705, 2012.

L. Prensa, J. M. Gimenez-amaya, A. Parent, J. Bernacer, and C. Cebrian, The nigrostriatal pathway: axonal collateralization and compartmental specificity, J Neural Transm Suppl, issue.73, pp.49-58, 2009.

F. Theisen, R. Leda, and V. Pozorski, Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease, Neuroimage Clin, vol.16, pp.557-63, 2017.

Y. Zhang, K. M. Larcher, B. Misic, and A. Dagher, Anatomical and functional organization of the human substantia nigra and its connections, Elife, vol.6, 2017.

A. D. Crocker, The regulation of motor control: an evaluation of the role of dopamine receptors in the substantia nigra, Rev Neurosci, vol.8, issue.1, pp.55-76, 1997.

G. Kronenberg, M. Balkaya, and V. Prinz, Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression, Biol Psychiatry, vol.72, issue.4, pp.273-81, 2012.

D. Shohamy and R. A. Adcock, Dopamine and adaptive memory, Trends Cogn Sci, vol.14, issue.10, pp.464-72, 2010.

M. Nakane, A. Tamura, T. Nagaoka, and K. Hirakawa, MR detection of secondary changes remote from ischemia: preliminary observations after occlusion of the middle cerebral artery in rats, AJNR Am J Neuroradiol, vol.18, issue.5, pp.945-50, 1997.

M. Nakajima, Y. Inatomi, T. Okigawa, T. Yonehara, and T. Hirano, Secondary signal change and an apparent diffusion coefficient decrease of the substantia nigra after striatal infarction, Stroke, vol.44, issue.1, pp.213-219, 2013.

B. Winter, P. Brunecker, J. B. Fiebach, G. J. Jungehulsing, G. Kronenberg et al., Striatal Infarction Elicits Secondary Extrafocal MRI Changes in Ipsilateral Substantia Nigra, PLoS One, vol.10, issue.9, p.136483, 2015.

F. Zhao, T. Kuroiwa, and N. Miyasaka, Characteristic changes in T(2)-value, apparent diffusion coefficient, and ultrastructure of substantia nigra evolving exofocal postischemic neuronal death in rats, Brain Res, vol.895, issue.1-2, pp.238-282, 2001.

M. Nakane, A. Tamura, N. Miyasaka, T. Nagaoka, and T. Kuroiwa, Astrocytic swelling in the ipsilateral substantia nigra after occlusion of the middle cerebral artery in rats, AJNR Am J Neuroradiol, vol.22, issue.4, pp.660-663, 2001.

L. A. Degiorgio, C. Dibinis, T. A. Milner, M. Saji, and B. T. Volpe, Histological and temporal characteristics of nigral transneuronal degeneration after striatal injury, Brain Res, vol.795, issue.1-2, pp.1-9, 1998.

V. Prinz, A. M. Hetzer, and S. Muller, MRI heralds secondary nigral lesion after brain ischemia in mice: a secondary time window for neuroprotection, J Cereb Blood Flow Metab, vol.35, issue.12, pp.1903-1912, 2015.

A. M. Daugherty and N. Raz, Appraising the Role of Iron in Brain Aging and Cognition: Promises and Limitations of MRI Methods, Neuropsychol Rev, vol.25, issue.3, pp.272-87, 2015.

S. J. Dixon, K. M. Lemberg, and M. R. Lamprecht, Ferroptosis: an iron-dependent form of nonapoptotic cell death, Cell, vol.149, issue.5, pp.1060-72, 2012.

C. Justicia, P. Ramos-cabrer, and M. Hoehn, MRI detection of secondary damage after stroke: chronic iron accumulation in the thalamus of the rat brain, Stroke, vol.39, issue.5, pp.1541-1548, 2008.

M. S. Thomsen, M. V. Andersen, P. R. Christoffersen, M. D. Jensen, J. Lichota et al., Neurodegeneration with inflammation is accompanied by accumulation of iron and ferritin in microglia and neurons, Neurobiol Dis, vol.81, pp.108-126, 2015.

C. Langkammer, N. Krebs, and W. Goessler, Quantitative MR imaging of brain iron: a postmortem validation study, Radiology, vol.257, issue.2, pp.455-62, 2010.

G. Kuchcinski, F. Munsch, and R. Lopes, Thalamic alterations remote to infarct appear as focal iron accumulation and impact clinical outcome, Brain, vol.140, issue.7, pp.1932-1978, 2017.

A. Fedorov, R. Beichel, and J. Kalpathy-cramer, 3D Slicer as an image computing platform for the Quantitative Imaging Network, Magn Reson Imaging, vol.30, issue.9, pp.1323-1364, 2012.

E. S. Van-etten, J. Van-der-grond, E. M. Dumas, S. J. Van-den-bogaard, M. A. Van-buchem et al., MRI Susceptibility Changes Suggestive of Iron Deposition in the Thalamus after Ischemic Stroke, Cerebrovasc Dis, vol.40, issue.1-2, pp.67-72, 2015.

P. Peran, G. Hagberg, and G. Luccichenti, Voxel-based analysis of R2* maps in the healthy human brain, J Magn Reson Imaging, vol.26, issue.6, pp.1413-1433, 2007.

E. Bates, S. M. Wilson, and A. P. Saygin, Voxel-based lesion-symptom mapping, Nat Neurosci, vol.6, issue.5, pp.448-50, 2003.

M. Duering and R. Schmidt, Remote changes after ischaemic infarcts: a distant target for therapy?, Brain, vol.140, issue.7, pp.1818-1838, 2017.

M. Saji and D. J. Reis, Delayed transneuronal death of substantia nigra neurons prevented by gammaaminobutyric acid agonist, Science, vol.235, issue.4784, pp.66-75, 1987.

K. Yamada, S. Goto, M. Yoshikawa, A. Okamura, and Y. Ushio, Involvement of N-methyl-D-aspartate receptor in the delayed transneuronal regression of substantia nigra neurons in rats, Brain Res, vol.743, issue.1-2, pp.233-242, 1996.

G. Rathnasamy, E. A. Ling, and C. Kaur, Consequences of iron accumulation in microglia and its implications in neuropathological conditions, CNS Neurol Disord Drug Targets, vol.12, issue.6, pp.785-98, 2013.

A. Cacciola, D. Milardi, and G. P. Anastasi, A Direct Cortico-Nigral Pathway as Revealed by Constrained Spherical Deconvolution Tractography in Humans, Front Hum Neurosci, vol.10, p.374, 2016.

J. H. Barbosa, A. C. Santos, and V. Tumas, Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2, Magn Reson Imaging, vol.33, issue.5, pp.559-65, 2015.

J. E. Harris and J. J. Eng, Individuals with the dominant hand affected following stroke demonstrate less impairment than those with the nondominant hand affected, Neurorehabil Neural Repair, vol.20, issue.3, pp.380-389, 2006.

M. Tanaka, M. J. Mcdonagh, and C. T. Davies, A comparison of the mechanical properties of the first dorsal interosseous in the dominant and non-dominant hand, Eur J Appl Physiol Occup Physiol, vol.53, issue.1, pp.17-20, 1984.

. Supplemetal-references,

F. Munsch, S. Sagnier, and J. Asselineau, Stroke Location Is an Independent Predictor of Cognitive Outcome, Stroke, vol.47, issue.1, pp.66-73, 2016.

G. Kuchcinski, F. Munsch, and R. Lopes, Thalamic alterations remote to infarct appear as focal iron accumulation and impact clinical outcome, Brain, vol.140, issue.7, pp.1932-1978, 2017.

A. Bigourdan, F. Munsch, and P. Coupe, Early Fiber Number Ratio Is a Surrogate of Corticospinal Tract Integrity and Predicts Motor Recovery After Stroke, Stroke, vol.47, issue.4, pp.1053-1062, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01294872

S. Sagnier, G. Catheline, and B. Dilharreguy, Admission Brain Cortical Volume: An Independent Determinant of Poststroke Cognitive Vulnerability, Stroke, vol.48, issue.8, pp.2113-2133, 2017.

V. Mathiowetz, G. Volland, N. Kashman, and K. Weber, Adult norms for the Box and Block Test of manual dexterity, Am J Occup Ther, vol.39, issue.6, pp.386-91, 1985.

J. E. Graham, G. V. Ostir, Y. F. Kuo, S. R. Fisher, and K. J. Ottenbacher, Relationship between test methodology and mean velocity in timed walk tests: a review, Arch Phys Med Rehabil, vol.89, issue.5, pp.865-72, 2008.

J. Desrosiers, R. Hebert, G. Bravo, and E. Dutil, Upper-extremity motor co-ordination of healthy elderly people, Age Ageing, vol.24, issue.2, pp.108-120, 1995.

S. Hwang and C. S. Song, Relationship between manual dexterity and the unified parkinson's disease rating scale-motor exam, J Phys Ther Sci, vol.28, issue.12, pp.3403-3409, 2016.

B. R. Bloem, J. Marinus, and Q. Almeida, Measurement instruments to assess posture, gait, and balance in Parkinson's disease: Critique and recommendations, Mov Disord, vol.31, issue.9, pp.1342-55, 2016.

Z. S. Nasreddine, N. A. Phillips, and V. Bedirian, MoCA: a brief screening tool for mild cognitive impairment, The Montreal Cognitive Assessment, vol.53, issue.4, pp.695-704, 2005.

B. Isaacs and A. T. Kennie, The Set test as an aid to the detection of dementia in old people, Br J Psychiatry, vol.123, issue.575, pp.467-70, 1973.

A. S. Zigmond and R. P. Snaith, The hospital anxiety and depression scale, Acta Psychiatr Scand, vol.67, issue.6, pp.361-70, 1983.

P. Peran, G. Hagberg, and G. Luccichenti, Voxel-based analysis of R2* maps in the healthy human brain, J Magn Reson Imaging, vol.26, issue.6, pp.1413-1433, 2007.

M. C. Keuken and B. U. Forstmann, A probabilistic atlas of the basal ganglia using 7 T MRI, Data Brief, vol.4, pp.577-82, 2015.

S. M. Smith and T. E. Nichols, Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference, Neuroimage, vol.44, issue.1, pp.83-98, 2009.

E. Bates, S. M. Wilson, and A. P. Saygin, Voxel-based lesion-symptom mapping, Nat Neurosci, vol.6, issue.5, pp.448-50, 2003.

C. Rorden, H. O. Karnath, and L. Bonilha, Improving lesion-symptom mapping, J Cogn Neurosci, vol.19, issue.7, pp.1081-1089, 2007.

G. Wu, G. Xi, Y. Hua, and O. Sagher, T2* magnetic resonance imaging sequences reflect brain tissue iron deposition following intracerebral hemorrhage, Transl Stroke Res, vol.1, issue.1, pp.31-35, 2010.

D. Aquino, A. Bizzi, and M. Grisoli, Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects, Radiology, vol.252, issue.1, pp.165-72, 2009.

G. Bartzokis, T. A. Tishler, and P. H. Lu, Brain ferritin iron may influence age-and genderrelated risks of neurodegeneration, Neurobiol Aging, vol.28, issue.3, pp.414-437, 2007.

R. Lees, J. Selvarajah, and C. Fenton, Test accuracy of cognitive screening tests for diagnosis of dementia and multidomain cognitive impairment in stroke, Stroke, vol.45, issue.10, pp.3008-3026, 2014.

S. Mehrabian, M. Raycheva, N. Petrova, A. Janyan, M. Petrova et al., Neuropsychological and neuroimaging markers in prediction of cognitive impairment after ischemic stroke: a prospective follow-up study, Neuropsychiatr Dis Treat, vol.11, pp.2711-2720, 2015.

J. C. Prisnie, K. M. Fiest, and S. B. Coutts, Validating screening tools for depression in stroke and transient ischemic attack patients, Int J Psychiatry Med, vol.51, issue.3, pp.262-77, 2016.

S. Sagnier, G. Catheline, B. Dilharreguy, F. Munsch, A. Bigourdan et al., Admission Brain Cortical Volume: An Independent Determinant of Poststroke Cognitive Vulnerability, Stroke, vol.48, issue.8, pp.2113-2133, 2017.

F. Munsch, S. Sagnier, J. Asselineau, A. Bigourdan, C. R. Guttmann et al., Stroke Location Is an Independent Predictor of Cognitive Outcome, Stroke, vol.47, issue.1, pp.66-73, 2016.

M. Duering and R. Schmidt, Remote changes after ischaemic infarcts: a distant target for therapy? Brain, vol.140, pp.1818-1838, 2017.

J. Zhang, Y. Zhang, S. Xing, Z. Liang, and J. Zeng, Secondary Neurodegeneration in Remote Regions After Focal Cerebral Infarction: A New Target for Stroke Management? Stroke, vol.43, pp.1700-1705, 2012.

B. Stieltjes, W. E. Kaufmann, P. Van-zijl, K. Fredericksen, G. D. Pearlson et al., Diffusion Tensor Imaging and Axonal Tracking in the Human Brainstem, NeuroImage, vol.14, issue.3, pp.723-758, 2001.

E. Matsusue, S. Sugihara, S. Fujii, T. Kinoshita, E. Ohama et al., Wallerian degeneration of the corticospinal tracts: postmortem MR-pathologic correlations, Acta Radiologica, vol.48, issue.6, pp.690-694, 2007.

R. Xie, M. Fang, and L. Zhou, Diffusion tensor imaging detects Wallerian degeneration of the corticospinal tract early after cerebral infarction, Neural Regen Res, vol.7, issue.12, pp.900-905, 2012.

Y. J. Chen, S. A. Nabavizadeh, A. Vossough, S. Kumar, L. A. Loevner et al., Wallerian Degeneration Beyond the Corticospinal Tracts: Conventional and Advanced MRI Findings: Wallerian Degeneration: Conventional & Advanced MRI Findings, Journal of Neuroimaging, vol.27, issue.3, pp.272-80, 2017.

M. Walberer, S. U. Jantzen, H. Backes, M. A. Rueger, M. H. Keuters et al., In-vivo detection of inflammation and neurodegeneration in the chronic phase after permanent embolic stroke in rats, Brain Research, vol.1581, pp.80-88, 2014.

T. Ogawa, Y. Yoshida, T. Okudera, K. Noguchi, H. Kado et al., Secondary thalamic degeneration after cerebral infarction in the middle cerebral artery distribution: evaluation with MR imaging, Radiology, vol.204, issue.1, pp.255-262, 1997.

S. Pappata, M. Levasseur, R. N. Gunn, R. Myers, C. Crouzel et al., Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195, Neurology, vol.55, issue.7, pp.1052-1056, 2000.

C. Li, X. Ling, S. Liu, A. Xu, Y. Zhang et al., Early detection of secondary damage in ipsilateral thalamus after acute infarction at unilateral corona radiata by diffusion tensor imaging and magnetic resonance spectroscopy, BMC Neurol, vol.11, issue.1, p.49, 2011.

A. Gerhard, J. Schwarz, R. Myers, R. Wise, and R. B. Banati, Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study, NeuroImage, vol.24, issue.2, pp.591-596, 2005.

M. Nakane, A. Tamura, N. Miyasaka, T. Nagaoka, and T. Kuroiwa, Astrocytic Swelling in the Ipsilateral Substantia Nigra after Occlusion of the Middle Cerebral Artery in Rats, AJNR Am J Neuroradiol, vol.22, issue.4, pp.660-663, 2001.

F. Zhao, T. Kuroiwa, N. Miyasaka, T. Nagaoka, M. Nakane et al., Characteristic changes in T 2 -value, apparent diffusion coefficient, and ultrastructure of substantia nigra evolving exofocal postischemic neuronal death in rats, Brain Research, vol.895, issue.1-2, pp.238-282, 2001.

M. Nakane, A. Tamura, T. Nagaoka, and K. Hirakawa, MR Detection of Secondary Changes Remote from Ischemia: Preliminary Observations after Occlusion of the Middle Cerebral Artery in Rats, AJNR Am J Neuroradiol, vol.18, issue.5, pp.945-50, 1997.

M. Nakane, A. Teraoka, and R. Asato, Degeneration of the Ipsilateral Substantia Nigra Following Cerebral Infarction in the Striatum, Stroke, vol.23, issue.3, pp.328-360, 1992.

M. Nakajima, Y. Inatomi, T. Okigawa, T. Yonehara, and T. Hirano, Secondary Signal Change and an Apparent Diffusion Coefficient Decrease of the Substantia Nigra After Striatal Infarction, Stroke, vol.44, issue.1, pp.213-219, 2013.

R. Tsai, L. Hsieh, S. Cheng, and C. Chen, Secondary pallidonigral degeneration mimicking recurrent acute stroke in clinical presentation and magnetic resonance imaging: a case report, BMC Neurol, vol.17, issue.1, p.215, 2017.

T. Kinoshita, T. Moritani, D. A. Shrier, H. Z. Wang, A. Hiwatashi et al., Secondary Degeneration of the Substantia Nigra and Corticospinal Tract after Hemorrhagic Middle Cerebral Artery Infarction: Di?usion-weighted MR Findings, Magn Reson Med Sci, vol.1, issue.3, p.4, 2002.

L. S. Forno, Reaction of the substantia nigra to massive basal ganglia infarction, Acta Neuropathologica, vol.62, issue.1-2, pp.96-102, 1983.

L. A. Degiorgio, C. Dibinis, T. A. Milner, M. Saji, and B. T. Volpe, Histological and temporal characteristics of nigral transneuronal degeneration after striatal injury. Brain Research, vol.795, pp.1-9, 1998.

V. Prinz, A. Hetzer, S. Müller, M. Balkaya, C. Leithner et al., MRI Heralds Secondary Nigral Lesion after Brain Ischemia in Mice: A Secondary Time Window for Neuroprotection, Journal of Cerebral Blood Flow & Metabolism, vol.35, issue.12, pp.1903-1912, 2015.

L. Gold and M. Lauritzen, Neuronal deactivation explains decreased cerebellar blood flow in response to focal cerebral ischemia or suppressed neocortical function, Proceedings of the National Academy of Sciences, vol.99, pp.7699-704, 2002.

J. C. Baron, M. G. Bousser, D. Comar, and P. Castaigne, Crossed cerebellar diaschisis" in human supratentorial brain infarction, Trans Am Neurol Assoc, vol.105, pp.459-461, 1981.

W. H. Sommer, C. Bollwein, K. M. Thierfelder, A. Baumann, H. Janssen et al., Crossed cerebellar diaschisis in patients with acute middle cerebral artery infarction: Occurrence and perfusion characteristics, Journal of Cerebral Blood Flow & Metabolism, vol.36, issue.4, pp.743-54, 2016.

D. Lin, J. T. Kleinman, R. J. Wityk, R. F. Gottesman, A. E. Hillis et al., Crossed Cerebellar Diaschisis in Acute Stroke Detected by Dynamic Susceptibility Contrast MR Perfusion Imaging, American Journal of Neuroradiology, vol.30, issue.4, pp.710-715, 2009.

J. Sobesky, A. Thiel, M. Ghaemi, R. H. Hilker, R. J. Jacobs et al., Crossed Cerebellar Diaschisis in Acute Human Stroke: A PET Study of Serial Changes and Response to Supratentorial Reperfusion, Journal of Cerebral Blood Flow & Metabolism, vol.25, issue.12, pp.1685-91, 2005.

Y. Liu, J. O. Karonen, J. Nuutinen, E. Vanninen, J. T. Kuikka et al., Crossed Cerebellar Diaschisis in Acute Ischemic Stroke: A Study with Serial SPECT and MRI, Journal of Cerebral Blood Flow & Metabolism, vol.27, issue.10, pp.1724-1756, 2007.

P. Jiménez-caballero, Crossed cerebellar atrophy: Update, Journal of Neurosciences in Rural Practice, vol.3, issue.3, p.235, 2012.

N. Panahian, T. Huang, and M. D. Maines, Enhanced neuronal expression of the oxidoreductase -biliverdin reductase -after permanent focal cerebral ischemia. Brain Research, vol.850, pp.1-13, 1999.

V. Sawlani, R. K. Gupta, M. K. Singh, and A. Kohli, MRI demonstration of Wallerian degeneration in various intracranial lesions and its clinical implications, Journal of the Neurological Sciences, vol.146, issue.2, pp.103-111, 1997.

H. Bouza, L. M. Dubowitz, M. Rutherford, and J. M. Pennock, Prediction of Outcome in Children with Congenital Hemiplegia: A Magnetic Resonance Imaging Study, Neuropediatrics, vol.25, issue.2, p.7, 1994.

G. Devetten, S. B. Coutts, M. D. Hill, M. Goyal, M. Eesa et al., Acute Corticospinal Tract Wallerian Degeneration Is Associated With Stroke Outcome, Stroke, vol.41, issue.4, pp.751-757, 2010.

A. Bigourdan, F. Munsch, P. Coupé, C. Guttmann, S. Sagnier et al., Early Fiber Number Ratio Is a Surrogate of Corticospinal Tract Integrity and Predicts Motor Recovery After Stroke, Stroke, vol.47, issue.4, pp.1053-1062, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01294872

G. Kuchcinski, F. Munsch, R. Lopes, A. Bigourdan, J. Su et al., Thalamic alterations remote to infarct appear as focal iron accumulation and impact clinical outcome, Brain, vol.140, issue.7, pp.1932-1978, 2017.

G. Kronenberg, M. Balkaya, V. Prinz, K. Gertz, J. S. Kirste et al., Exofocal Dopaminergic Degeneration as Antidepressant Target in Mouse Model of Poststroke Depression, Biological Psychiatry, vol.72, issue.4, pp.273-81, 2012.

B. Winter, P. Brunecker, J. B. Fiebach, G. J. Jungehulsing, G. Kronenberg et al., Striatal Infarction Elicits Secondary Extrafocal MRI Changes in Ipsilateral Substantia Nigra, vol.10, p.136483, 2015.

M. T. Viscomi and M. Molinari, Remote Neurodegeneration: Multiple Actors for One Play, Molecular Neurobiology, vol.50, issue.2, pp.368-89, 2014.

V. E. Koliatsos, T. M. Dawson, A. Kecojevic, Y. Zhou, Y. Wang et al., Cortical interneurons become activated by deafferentation and instruct the apoptosis of pyramidal neurons, Proceedings of the National Academy of Sciences, vol.101, pp.14264-14273, 2004.

F. Block, M. Dihné, and M. Loos, Inflammation in areas of remote changes following focal brain lesion, Progress in Neurobiology, vol.75, issue.5, pp.342-65, 2005.

L. Galluzzi, O. Kepp, and G. Kroemer, Mitochondria: master regulators of danger signalling, Nature Reviews Molecular Cell Biology, vol.13, issue.12, pp.780-788, 2012.

S. Xing, Y. Zhang, J. Li, J. Zhang, Y. Li et al., Beclin 1 knockdown inhibits autophagic activation and prevents the secondary neurodegenerative damage in the ipsilateral thalamus following focal cerebral infarction, Autophagy, vol.8, issue.1, pp.63-76, 2012.

M. He, S. Xing, B. Yang, L. Zhao, H. Hua et al., Ebselen attenuates oxidative DNA damage and enhances its repair activity in the thalamus after focal cortical infarction in hypertensive rats, Brain Research, pp.83-92, 1181.

K. Yamada, S. Goto, M. Yoshikawa, A. Okamura, and Y. Ushio, Involvement of N-methyl-d-aspartate receptor in the delayed transneuronal regression of substantia nigra neurons in rats. Brain Research, vol.743, pp.233-242, 1996.

J. P. Bolam, J. J. Hanley, P. Booth, and M. D. Bevan, Synaptic organisation of the basal ganglia, Journal of Anatomy, vol.196, issue.4, pp.527-569, 2000.

L. Prensa, J. M. Giménez-amaya, A. Parent, J. Bernácer, and C. Cebrián, The Nigrostriatal Pathway: Axonal Collateralization and Compartmental Specificity. Birth, Life and Death of Dopaminergic Neurons in the Substantia Nigra, pp.49-58, 2009.

M. Carpenter and J. Sutin, Human neuroanatomy 8th edition, 1983.

L. A. Massey and T. A. Yousry, Anatomy of the Substantia Nigra and Subthalamic Nucleus on MR Imaging. Neuroimaging Clinics of North America, vol.20, pp.7-27, 2010.

J. Fearnley and A. J. Lees, Ageing and Parkinson's disease: substantia nigra regional selectivity, Brain, vol.114, pp.2283-2301, 1991.

J. L. Lanciego, N. Luquin, and J. A. Obeso, Functional Neuroanatomy of the Basal Ganglia. Cold Spring Harbor Perspectives in Medicine, vol.2, pp.9621-009621, 2012.

M. R. Delong, Primate models of movement disorders of basal ganglia origin, Trends in Neurosciences, vol.13, issue.7, pp.281-286, 1990.

R. L. Albin, A. B. Young, and J. B. Penney, The functional anatomy of basal ganglia disorders, Trends in Neurosciences, vol.12, issue.10, pp.366-75, 1989.

E. Shink, M. Bevan, J. P. Bolam, and Y. Smith, The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey, Neuroscience, vol.73, issue.2, pp.335-57, 1996.

C. Cebrián, A. Parent, and L. Prensa, Patterns of axonal branching of neurons of the substantia nigra pars reticulata and pars lateralis in the rat, The Journal of Comparative Neurology, vol.492, issue.3, pp.349-69, 2005.

R. Beckstead, V. Domesick, and W. Nauta, Efferent connections of the substantia nigra and ventral tegmental area in the rat, Brain Res, vol.175, issue.2, pp.191-217, 1979.

A. Parent and L. Hazrati, Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry, Brain Res Brain Res Rev, vol.20, issue.1, pp.128-54, 1995.

A. R. Granata and S. T. Kitai, Inhibitory substantia nigra inputs to the pedunculopontine neurons, Exp Brain Res, vol.86, issue.3, pp.459-66, 1991.

M. Hajós and S. A. Greenfield, Synaptic connections between pars compacta and pars reticulata neurones: electrophysiological evidence for functional modules within the substantia nigra, Brain Research, vol.660, issue.2, pp.216-240, 1994.

M. Damlama, B. , and T. , Axon collaterals of pars retlculata projection neurons synapse on pars compacta neurons, Soc Neurosct Abstr, 1432.

J. P. Bolam and Y. Smith, The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat, Brain Research, vol.529, issue.1-2, pp.57-78, 1990.

M. Watabe-uchida, L. Zhu, S. K. Ogawa, A. Vamanrao, and N. Uchida, Whole-Brain Mapping of Direct Inputs to Midbrain Dopamine Neurons, Neuron, vol.74, issue.5, pp.858-73, 2012.

T. C. Jhou, H. L. Fields, M. G. Baxter, C. B. Saper, and P. C. Holland, The Rostromedial Tegmental Nucleus (RMTg), a GABAergic Afferent to Midbrain Dopamine Neurons, Encodes Aversive Stimuli and Inhibits Motor Responses, Neuron, vol.61, issue.5, pp.786-800, 2009.

J. Kaufling, P. Veinante, S. A. Pawlowski, M. Freund-mercier, and M. Barrot, Afferents to the GABAergic tail of the ventral tegmental area in the rat, The Journal of Comparative Neurology, vol.513, issue.6, pp.597-621, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00365803

A. Hertel, M. Weppner, H. Baas, M. Schreiner, and F. D. Maul, Quantification of IBZM dopamine receptor SPET in de novo Parkinson patients before and during therapy, Nucl Med Commun, vol.18, issue.9, pp.811-833, 1997.

S. Geisler, M. Marinelli, B. Degarmo, M. L. Becker, and A. J. Freiman, Prominent Activation of Brainstem and Pallidal Afferents of the Ventral Tegmental Area by Cocaine, Neuropsychopharmacology, vol.33, issue.11, pp.2688-700, 2008.

A. Björklund and S. B. Dunnett, Dopamine neuron systems in the brain: an update. Trends in Neurosciences, vol.30, pp.194-202, 2007.

S. N. Haber and B. Knutson, The Reward Circuit: Linking Primate Anatomy and Human Imaging, Neuropsychopharmacology, vol.35, issue.1, pp.4-26, 2010.

S. J. Cragg, J. Baufreton, Y. Xue, J. P. Bolam, and M. D. Bevan, Synaptic release of dopamine in the subthalamic nucleus, European Journal of Neuroscience, vol.20, issue.7, pp.1788-802, 2004.

D. M. Friend and A. V. Kravitz, Working together: basal ganglia pathways in action selection, Trends in Neurosciences, vol.37, issue.6, pp.301-304, 2014.

E. H. Simpson, C. Kellendonk, and E. Kandel, A Possible Role for the Striatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia, Neuron, vol.65, issue.5, pp.585-96, 2010.

W. R. Marchand, J. N. Lee, Y. Suchy, S. Johnson, J. Thatcher et al., Aberrant functional connectivity of cortico-basal ganglia circuits in major depression, Neuroscience Letters, vol.514, issue.1, pp.86-90, 2012.

D. Dybdal, P. A. Forcelli, M. Dubach, M. Oppedisano, A. Holmes et al., Topography of dyskinesias and torticollis evoked by inhibition of substantia nigra pars reticulata: Snpr-Evoked Dyskinesias and Torticollis. Movement Disorders, vol.28, pp.460-468, 2013.

S. Tan, H. Hartung, S. Schievink, T. Sharp, and Y. Temel, High-Frequency Stimulation of the Substantia Nigra Induces Serotonin-Dependent Depression-Like Behavior in Animal Models, Biological Psychiatry, vol.73, issue.2, pp.1-3, 2013.

S. M. Stahl, Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 2008.

J. A. Obeso, M. C. Rodriguez-oroz, M. Rodriguez, J. L. Lanciego, J. Artieda et al., Pathophysiology of the basal ganglia in Parkinson's disease, Trends in Neurosciences, vol.23, pp.8-19, 2000.

G. Drui, S. Carnicella, C. Carcenac, M. Favier, A. Bertrand et al., Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease. Molecular Psychiatry, vol.19, pp.358-67, 2014.

C. Winter, A. Von-rumohr, A. Mundt, D. Petrus, J. Klein et al., Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats, Behavioural Brain Research, vol.184, issue.2, pp.133-174, 2007.

D. Cunha, C. Wietzikoski, S. Wietzikoski, E. C. Miyoshi, E. Ferro et al., Evidence for the substantia nigra pars compacta as an essential component of a memory system independent of the hippocampal memory system, Neurobiology of Learning and Memory, vol.79, issue.3, pp.236-278, 2003.

N. Solari, A. Bonito-oliva, G. Fisone, and R. Brambilla, Understanding cognitive deficits in Parkinson's disease: lessons from preclinical animal models, Learning & Memory, vol.20, issue.10, pp.592-600, 2013.

M. Lima, M. L. Andersen, A. B. Reksidler, M. Vital, and S. Tufik, The Role of the Substantia Nigra Pars Compacta in Regulating Sleep Patterns in Rats, PLoS ONE, vol.2, issue.6, p.513, 2007.

R. A. Wise, Roles for nigrostriatal-not just mesocorticolimbic-dopamine in reward and addiction, Trends in Neurosciences, vol.32, issue.10, pp.517-541, 2009.

D. Belin, A. Belin-rauscent, J. E. Murray, and B. J. Everitt, Addiction: failure of control over maladaptive incentive habits. Current Opinion in Neurobiology, vol.23, pp.564-72, 2013.

W. L. Hirsch, S. S. Kemp, A. J. Martinez, H. Curtin, R. E. Latchaw et al., Anatomy of the Brainstem, AJNR Am J Neuroradiol, vol.10, issue.6, pp.923-928, 1989.

B. P. Drayer, Imaging of the Aging Brain, Radiology, vol.166, issue.3, p.10, 1988.

J. Rutledge, S. Hilal, A. Silver, R. Defendini, and S. Fahn, Study of movement disorders and brain iron by MR, American Journal of Roentgenology, vol.149, issue.2, pp.365-79, 1987.

C. M. Morris, J. M. Candy, A. E. Oakley, C. A. Bloxham, and J. A. Edwardson, Histochemical distribution of nonhaem iron in the human brain, Acta Anat, 1992.

B. D. Flannigan, W. G. Bradley, J. C. Mazziotta, W. Rauschning, J. R. Bentson et al., Magnetic resonance imaging of the brainstem: normal structure and basic functional anatomy, Radiology, vol.154, issue.2, pp.375-83, 1985.

W. S. Enochs, P. Petherick, A. Bogdanova, U. Mohr, and R. Weissleder, Paramagnetic metal scavenging by melanin: MR imaging, Radiology, vol.204, pp.417-423, 1997.
DOI : 10.1148/radiology.204.2.9240529

M. Sasaki, E. Shibata, K. Tohyama, J. Takahashi, K. Otsuka et al., Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson??s disease: NeuroReport, vol.17, pp.1215-1223, 2006.

N. I. Keren, C. T. Lozar, K. C. Harris, P. S. Morgan, and M. A. Eckert, In vivo mapping of the human locus coeruleus, NeuroImage, vol.47, issue.4, pp.1261-1268, 2009.

S. Lehéricy, E. Bardinet, C. Poupon, M. Vidailhet, and C. François, 7 tesla magnetic resonance imaging: A closer look at substantia nigra anatomy in Parkinson's disease: 7T MRI in PD, Movement Disorders, vol.29, issue.13, pp.1574-81, 2014.

B. Yao, T. Li, P. Gelderen, K. Shmueli, J. Dezwart et al., Susceptibility contrast in high field MRI of human brain as a function of tissue iron content, NeuroImage, vol.44, issue.4, pp.1259-66, 2009.

C. Mueller, B. Pinter, E. Reiter, M. Schocke, C. Scherfler et al., Visualization of nigrosome 1 and its loss in PD: Pathoanatomical correlation and in vivo 7T MRI, Neurology, vol.82, pp.1752-1752, 2014.

Y. Zhang, K. Larcher, B. Misic, and A. Dagher, Anatomical and functional organization of the human substantia nigra and its connections, vol.6, p.26653, 2017.

R. Chowdhury, C. Lambert, R. J. Dolan, and E. Düzel, Parcellation of the human substantia nigra based on anatomical connectivity to the striatum, NeuroImage, vol.81, pp.191-199, 2013.

D. S. Margulies, S. S. Ghosh, A. Goulas, M. Falkiewicz, J. M. Huntenburg et al., Situating the default-mode network along a principal gradient of macroscale cortical organization, Proceedings of the National Academy of Sciences, vol.113, pp.12574-12583, 2016.

M. Mesulam, From sensation to cognition, Brain, vol.121, issue.6, pp.1013-52, 1998.
DOI : 10.1093/brain/121.6.1013

URL : https://academic.oup.com/brain/article-pdf/121/6/1013/17863894/1211013.pdf

B. Todorich, J. M. Pasquini, C. I. Garcia, P. M. Paez, and J. R. Connor, Oligodendrocytes and myelination: The role of iron, Glia, vol.57, issue.5, pp.467-78, 2009.

R. R. Crichton, Inorganic biochemistry of iron metabolism from molecular mechanisms to clinical consequences

A. M. Daugherty and N. Raz, Appraising the Role of Iron in Brain Aging and Cognition: Promises and Limitations of MRI Methods, Neuropsychology Review, vol.25, issue.3, pp.272-87, 2015.

M. Kruszewski, Labile iron pool: the main determinant of cellular response to oxidative stress. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.531, pp.81-92, 2003.

J. Melis, H. Van-steeg, and M. Luijten, Oxidative DNA Damage and Nucleotide Excision Repair, Antioxidants & Redox Signaling, vol.18, issue.18, pp.2409-2428, 2013.
DOI : 10.1089/ars.2012.5036

URL : http://europepmc.org/articles/pmc3671630?pdf=render

J. B. Kwok, Role of epigenetics in Alzheimer's and Parkinson's disease, Epigenomics, vol.2, issue.5, pp.671-82, 2010.

A. Catalá, Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chemistry and Physics of Lipids, vol.157, pp.1-11, 2009.

Y. Xie, W. Hou, X. Song, Y. Yu, J. Huang et al., Ferroptosis: process and function, Cell Death & Differentiation, vol.23, issue.3, pp.369-79, 2016.
DOI : 10.1038/cdd.2015.158

URL : https://www.nature.com/articles/cdd2015158.pdf

R. J. Ward, F. A. Zucca, J. H. Duyn, R. R. Crichton, and L. Zecca, The role of iron in brain ageing and neurodegenerative disorders. The Lancet Neurology, vol.13, pp.1045-60, 2014.

N. Singh, S. Haldar, A. K. Tripathi, K. Horback, J. Wong et al., Brain Iron Homeostasis: From Molecular Mechanisms To Clinical Significance and Therapeutic Opportunities, Antioxidants & Redox Signaling, vol.20, issue.8, pp.1324-63, 2014.
DOI : 10.1089/ars.2012.4931

URL : http://europepmc.org/articles/pmc3935772?pdf=render

W. A. Jeff-eries, M. R. Brandon, S. V. Hunt, A. F. Williams, K. C. Gatter et al., Transferrin receptor on endothelium of brain capillaries, Nature, vol.312, pp.162-63, 1984.

I. A. Simpson, P. Ponnuru, M. E. Klinger, R. L. Myers, K. Devraj et al., A Novel Model for Brain Iron Uptake: Introducing the Concept of Regulation, Journal of Cerebral Blood Flow & Metabolism, vol.35, issue.1, pp.48-57, 2015.

T. Moos, T. Skjoerringe, S. Gosk, and E. H. Morgan, Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1: Iron transport at the blood-brain barrier, Journal of Neurochemistry, vol.98, issue.6, pp.1946-58, 2006.

M. W. Boserup, J. Lichota, D. Haile, and T. Moos, Heterogenous distribution of ferroportin-containing neurons in mouse brain, BioMetals, vol.24, issue.2, pp.357-75, 2011.
DOI : 10.1007/s10534-010-9405-2

E. Nemeth, M. S. Tuttle, J. Powelson, M. B. Vaughn, A. Donovan et al., Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization, Science, vol.306, issue.5704, pp.2090-2093, 2004.
DOI : 10.1126/science.1104742

P. Urrutia, P. Aguirre, A. Esparza, V. Tapia, N. P. Mena et al., Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells, Journal of Neurochemistry, vol.126, issue.4, pp.541-550, 2013.

B. Todorich, X. Zhang, B. Slagle-webb, W. E. Seaman, and J. R. Connor, Tim-2 is the receptor for H-ferritin on oligodendrocytes, Journal of Neurochemistry, vol.107, issue.6, pp.1495-505, 2008.
DOI : 10.1111/j.1471-4159.2008.05678.x

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1471-4159.2008.05678.x

R. Dringen, G. M. Bishop, M. Koeppe, T. N. Dang, and S. R. Robinson, The Pivotal Role of Astrocytes in the Metabolism of Iron in the Brain, Neurochemical Research, vol.32, issue.11, pp.1884-90, 2007.

O. Kakhlon and Z. I. Cabantchik, The labile iron pool: characterization, measurement, and participation in cellular processes, Free Radic Biol Med, vol.33, issue.8, pp.1037-1083, 2002.

M. L. Wallander, E. A. Leibold, and R. S. Eisenstein, Molecular control of vertebrate iron homeostasis by iron regulatory proteins, Biochimica et Biophysica Acta (BBA) -Molecular Cell Research, vol.1763, issue.7, pp.668-89, 2006.
DOI : 10.1016/j.bbamcr.2006.05.004

URL : https://doi.org/10.1016/j.bbamcr.2006.05.004

R. R. Crichton, D. T. Dexter, and R. J. Ward, Brain iron metabolism and its perturbation in neurological diseases, Journal of Neural Transmission, vol.118, issue.3, pp.301-315, 2011.
DOI : 10.1007/978-3-7091-1001-0_1

J. R. Connor, B. S. Snyder, P. Arosio, D. A. Loeffler, and P. Lewitt, A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains, Journal of Neurochemistry, vol.65, issue.2, pp.717-741, 1995.

P. Ramos, A. Santos, N. R. Pinto, R. Mendes, T. Magalhães et al., Iron levels in the human brain: A post-mortem study of anatomical region differences and age-related changes, Journal of Trace Elements in Medicine and Biology, vol.28, issue.1, pp.13-20, 2014.

A. J. Farrall and J. M. Wardlaw, Blood-brain barrier: Ageing and microvascular disease -systematic review and meta-analysis, Neurobiology of Aging, vol.30, issue.3, pp.337-52, 2009.
DOI : 10.1016/j.jns.2009.02.089

M. L. Block, L. Zecca, and J. Hong, Microglia-mediated neurotoxicity: uncovering the molecular mechanisms, Nature Reviews Neuroscience, vol.8, issue.1, pp.57-69, 2007.
DOI : 10.1038/nrn2038

D. W. Killilea, S. L. Wong, H. S. Cahaya, H. Atamna, and B. N. Ames, Iron Accumulation during Cellular Senescence, Annals of the New York Academy of Sciences, vol.1019, issue.1, pp.365-372, 2004.

L. Zecca, M. Youdim, P. Riederer, J. R. Connor, and R. R. Crichton, Iron, brain ageing and neurodegenerative disorders, Nature Reviews Neuroscience, vol.5, issue.11, pp.863-73, 2004.
DOI : 10.1038/nrn1537

E. Kienzl, L. Puchinger, K. Jellinger, W. Linert, H. Stachelberger et al., The role of transition metals in the pathogenesis of Parkinson's disease, Journal of the Neurological Sciences, vol.134, pp.69-78, 1995.

E. C. Hirsch, J. Brandel, P. Galle, F. Javoy-agid, and Y. Agid, Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X-Ray Microanalysis, Journal of Neurochemistry, vol.56, issue.2, pp.446-51, 1991.

R. Kortekaas, K. L. Leenders, J. Van-oostrom, W. Vaalburg, J. Bart et al., Blood-brain barrier dysfunction in parkinsonian midbrain in vivo, Annals of Neurology, vol.57, issue.2, pp.176-185, 2005.
DOI : 10.1002/ana.20369

J. Salazar, N. Mena, S. Hunot, A. Prigent, D. Alvarez-fischer et al., Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease, Proceedings of the National Academy of Sciences, vol.105, pp.18578-83, 2008.

M. Boll, J. Sotelo, E. Otero, M. Alcaraz-zubeldia, and C. Rios, Reduced ferroxidase activity in the cerebrospinal ¯uid from patients with Parkinson's disease, Neuroscience Letters, vol.4, 1999.

P. G. Mastroberardino, E. K. Hoffman, M. P. Horowitz, R. Betarbet, G. Taylor et al., A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease, Neurobiology of Disease, vol.34, issue.3, pp.417-448, 2009.

F. A. Zucca, E. Basso, F. A. Cupaioli, E. Ferrari, D. Sulzer et al., Neuromelanin of the Human Substantia Nigra: An Update, Neurotoxicity Research, vol.25, issue.1, pp.13-23, 2014.

C. Justicia, P. Ramos-cabrer, and M. Hoehn, MRI Detection of Secondary Damage After Stroke: Chronic Iron Accumulation in the Thalamus of the Rat Brain, Stroke, vol.39, issue.5, pp.1541-1548, 2008.

M. S. Thomsen, M. V. Andersen, P. R. Christoffersen, M. D. Jensen, J. Lichota et al., Neurodegeneration with inflammation is accompanied by accumulation of iron and ferritin in microglia and neurons, Neurobiology of Disease, vol.81, pp.108-126, 2015.

S. Sastry and G. W. Arendash, Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex, Neuroscience, vol.67, issue.3, pp.649-66, 1995.

R. A. Taylor and L. H. Sansing, Microglial Responses after Ischemic Stroke and Intracerebral Hemorrhage, Clinical and Developmental Immunology, vol.2013, pp.1-10, 2013.

M. Wirenfeldt, L. Dissing-olesen, A. Babcock, A. Nielsen, M. Meldgaard et al., Population Control of Resident and Immigrant Microglia by Mitosis and Apoptosis. The American Journal of Pathology, vol.171, pp.617-648, 2007.

J. J. Neher, U. Neniskyte, J. Zhao, A. Bal-price, A. M. Tolkovsky et al., Inhibition of Microglial Phagocytosis Is Sufficient To Prevent Inflammatory Neuronal Death. The Journal of Immunology, vol.186, pp.4973-83, 2011.

H. Bidmon, B. Emde, E. Oermann, R. Kubitz, O. W. Witte et al., Heme Oxygenase-1 (HSP-32) and Heme Oxygenase-2 Induction in Neurons and Glial Cells of Cerebral Regions and Its Relation to Iron Accumulation after Focal Cortical Photothrombosis, Experimental Neurology, vol.168, issue.1, pp.1-22, 2001.

J. R. Connor and S. L. Menzies, Cellular management of iron in the brain, Journal of the Neurological Sciences, vol.134, pp.33-44, 1995.

G. B. Chavhan, P. S. Babyn, B. Thomas, M. M. Shroff, and E. M. Haacke, Principles, Techniques, and Applications of T2*-based MR Imaging and Its Special Applications, RadioGraphics, vol.29, issue.5, pp.1433-1482, 2009.

P. Péran, G. Hagberg, G. Luccichenti, A. Cherubini, V. Brainovich et al., Voxel-based analysis of R2* maps in the healthy human brain, Journal of Magnetic Resonance Imaging, vol.26, issue.6, pp.1413-1433, 2007.

M. M. Lewis, G. Du, J. Baccon, A. M. Snyder, B. Murie et al., Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes: R2* and QSM Reflect Pathology in Parkinsonism. Movement Disorders, 2018.

C. Langkammer, N. Krebs, W. Goessler, E. Scheurer, F. Ebner et al., Quantitative MR Imaging of Brain Iron: A Postmortem Validation Study, Radiology, vol.257, issue.2, pp.455-62, 2010.

M. J. House, . St, T. G. Pierre, K. V. Kowdley, T. Montine et al., Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients. Magnetic Resonance in Medicine, vol.57, pp.172-80, 2007.

P. A. Hardy, D. Gash, R. Yokel, A. Andersen, Y. Ai et al., Correlation of R2 with total iron concentration in the brains of rhesus monkeys, Journal of Magnetic Resonance Imaging, vol.21, issue.2, pp.118-145, 2005.

P. Dusek, M. Dezortova, and J. Wuerfel, Imaging of Iron, International Review of Neurobiology, pp.195-239, 2013.

C. Langkammer, F. Schweser, N. Krebs, A. Deistung, W. Goessler et al., Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study, NeuroImage, vol.62, issue.3, pp.1593-1602, 2012.

A. Deistung, A. Schäfer, F. Schweser, U. Biedermann, R. Turner et al., Toward in vivo histology: A comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2?-imaging at ultra-high magnetic field strength, NeuroImage, vol.65, pp.299-314, 2013.

A. Deistung, F. Schweser, and J. R. Reichenbach, Overview of Quantitative Susceptibility Mapping. NMR in Biomedicine, vol.30, p.3569, 2017.

J. F. Schenck, Imaging of brain iron by magnetic resonance: T2 relaxation at different field strengths, Journal of the Neurological Sciences, vol.134, pp.10-18, 1995.

C. M. Morris, J. M. Candy, A. B. Keith, A. E. Oakley, G. A. Taylor et al., Brain iron homeostasis, Journal of Inorganic Biochemistry, vol.47, issue.1, pp.257-65, 1992.

E. M. Haacke, N. Cheng, M. J. House, Q. Liu, J. Neelavalli et al., Imaging iron stores in the brain using magnetic resonance imaging. Magnetic Resonance Imaging, vol.23, pp.1-25, 2005.

J. C. Salgado, A. Olivera-nappa, Z. P. Gerdtzen, V. Tapia, E. C. Theil et al., Mathematical modeling of the dynamic storage of iron in ferritin, BMC Systems Biology, vol.4, issue.1, p.147, 2010.

E. Mills, X. Dong, F. Wang, and H. Xu, Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders, Future Medicinal Chemistry, vol.2, issue.1, pp.51-64, 2010.

J. F. Schenck and E. A. Zimmerman, High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR in Biomedicine, vol.17, pp.433-478, 2004.

H. G. Kwon and S. H. Jang, Differences in neural connectivity between the substantia nigra and ventral tegmental area in the human brain, Front Hum Neurosci, vol.8, pp.41-49, 2014.

A. Cacciola, D. Milardi, G. P. Anastasi, G. A. Basile, P. Ciolli et al., A Direct Cortico-Nigral Pathway as Revealed by Constrained Spherical Deconvolution Tractography in Humans, Front Hum Neurosci, vol.10, 2016.

J. Barbosa, A. C. Santos, V. Tumas, M. Liu, W. Zheng et al., Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2*. Magnetic Resonance Imaging, vol.33, pp.559-65, 2015.

M. He, S. Xing, B. Yang, L. Zhao, H. Hua et al., Ebselen attenuates oxidative DNA damage and enhances its repair activity in the thalamus after focal cortical infarction in hypertensive rats, Brain Research, pp.83-92, 1181.

D. Devos, C. Moreau, J. C. Devedjian, J. Kluza, M. Petrault et al., Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease, Antioxidants & Redox Signaling, vol.21, issue.2, pp.195-210, 2014.

, Serment d'Hippocrate

, Au moment d'être admis à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Admis dans l'intimité des personnes, je tairai les secrets qui me seront confiés. Reçu à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ferai tout pour soulager les souffrances. Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses

, Version validée et mise à jour par le Conseil National de l'Ordre des Médecins (05, p.1, 2012.